{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:48:45Z","timestamp":1787496525250,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41431-024-01771-z","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T23:18:01Z","timestamp":1736205481000},"page":"688-691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predicting the phenotype of Pompe Disease from features of GAA variants"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-4307","authenticated-orcid":false,"given":"Geetanjali","family":"Rajamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2943-2136","authenticated-orcid":false,"given":"Nishitha R.","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth A.","family":"Stafki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter I.","family":"Karachunski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4270-7325","authenticated-orcid":false,"given":"Peter B.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"1771_CR1","doi-asserted-by":"publisher","first-page":"9641","DOI":"10.1073\/pnas.83.24.9641","volume":"83","author":"F Martiniuk","year":"1986","unstructured":"Martiniuk F, Mehler M, Pellicer A, Tzall S, La Badie G, Hobart C, et al. Isolation of a cDNA for human acid alpha-glucosidase and detection of genetic heterogeneity for mRNA in three alpha-glucosidase-deficient patients. Proc Natl Acad Sci USA. 1986;83:9641\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1771_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/bj0860011","volume":"86","author":"HG Hers","year":"1963","unstructured":"Hers HG. \u03b1-Glucosidase deficiency in generalized glycogen-storage disease (Pompe\u2019s disease). Biochem J. 1963;86:11\u20136.","journal-title":"Biochem J"},{"key":"1771_CR3","unstructured":"Pompe Disease | National Institute of Neurological Disorders and Stroke [Internet]. [cited 2024 Jan 13]. Available from: https:\/\/www.ninds.nih.gov\/health-information\/disorders\/pompe-disease."},{"key":"1771_CR4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/jnnp.23.4.302","volume":"23","author":"JM Holmes","year":"1960","unstructured":"Holmes JM, Houghton CR, Woolf AL. A Myopathy presenting in adult life with features suggestive of glycogen storage disease. J Neurol, Neurosurg Psychiatry. 1960;23:302\u201311.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"1771_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","volume":"356","author":"H Van den Hout","year":"2000","unstructured":"Van den Hout H, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet. 2000;356:397\u20138.","journal-title":"Lancet"},{"key":"1771_CR6","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","volume":"113","author":"JMP Van den Hout","year":"2004","unstructured":"Van den Hout JMP, Kamphoven JHJ, Winkel LPF, Arts WFM, De Klerk JBC, et al. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics. 2004;113:e448\u201357.","journal-title":"Pediatrics"},{"key":"1771_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","volume":"149","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Nicolino M, Voit T, Rogers RC, Tsai ACH, Waterson J, et al. Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. J Pediatr. 2006;149:89\u201397.","journal-title":"J Pediatr"},{"key":"1771_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.20019","volume":"55","author":"LPF Winkel","year":"2004","unstructured":"Winkel LPF, Van den Hout JMP, Kamphoven JHJ, Disseldorp JAM, Remmerswaal M, Arts WFM, et al. Enzyme replacement therapy in late-onset Pompe\u2019s disease: a three-year follow-up. Ann Neurol. 2004;55:495\u2013502.","journal-title":"Ann Neurol"},{"key":"1771_CR9","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT van der Ploeg","year":"2010","unstructured":"van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, et al. A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N. Engl J Med. 2010;362:1396\u2013406.","journal-title":"N. Engl J Med"},{"key":"1771_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/GIM.0b013e318211a7e1","volume":"13","author":"RY Wang","year":"2011","unstructured":"Wang RY, Bodamer OA, Watson MS, Wilcox WR. ACMG Work Group on Diagnostic Confirmation of Lysosomal Storage Diseases. Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Genet Med. 2011;13:457\u201384.","journal-title":"Genet Med"},{"key":"1771_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ymgme.2012.09.003","volume":"107","author":"SCA Wens","year":"2012","unstructured":"Wens SCA, Kroos MA, de Vries JM, Hoogeveen-Westerveld M, Wijgerde MGJM, van Doorn PA, et al. Remarkably low fibroblast acid \u03b1-glucosidase activity in three adults with Pompe disease. Mol Genet Metab. 2012;107:485\u20139.","journal-title":"Mol Genet Metab"},{"key":"1771_CR12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s10038-021-00935-9","volume":"66","author":"MA Viamonte","year":"2021","unstructured":"Viamonte MA, Filipp SL, Zaidi Z, Gurka MJ, Byrne BJ, Kang PB. Phenotypic implications of pathogenic variant types in Pompe disease. J Hum Genet. 2021;66:1089\u201399.","journal-title":"J Hum Genet"},{"key":"1771_CR13","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/humu.20374","volume":"27","author":"ALE Montalvo","year":"2006","unstructured":"Montalvo ALE, Bembi B, Donnarumma M, Filocamo M, Parenti G, Rossi M, et al. Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II. Hum Mutat. 2006;27:999\u20131006.","journal-title":"Hum Mutat"},{"key":"1771_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/humu.10286","volume":"23","author":"MMP Hermans","year":"2004","unstructured":"Hermans MMP, van Leenen D, Kroos MA, Beesley CE, Van Der Ploeg AT, Sakuraba H, et al. Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II. Hum Mutat. 2004;23:47\u201356.","journal-title":"Hum Mutat"},{"key":"1771_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymgme.2012.04.027","volume":"106","author":"TT Patel","year":"2012","unstructured":"Patel TT, Banugaria SG, Case LE, Wenninger S, Schoser B, Kishnani PS. The impact of antibodies in late-onset Pompe disease: a case series and literature review. Mol Genet Metab. 2012;106:301\u20139.","journal-title":"Mol Genet Metab"},{"key":"1771_CR16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/mus.21933","volume":"43","author":"DS Bali","year":"2011","unstructured":"Bali DS, Tolun AA, Goldstein JL, Dai J, Kishnani PS. Molecular analysis and protein processing in late-onset Pompe disease patients with low levels of acid \u03b1-glucosidase activity. Muscle Nerve. 2011;43:665\u201370.","journal-title":"Muscle Nerve"},{"key":"1771_CR17","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/mus.24653","volume":"51","author":"A Echaniz-Laguna","year":"2015","unstructured":"Echaniz-Laguna A, Carlier RY, Laloui K, Carlier P, Salort-Campana E, Pouget J, et al. SHOULD patients with asymptomatic pompe disease be treated? A nationwide study in france. Muscle Nerve. 2015;51:884\u20139.","journal-title":"Muscle Nerve"},{"key":"1771_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpeds.2013.03.002","volume":"163","author":"ME Elder","year":"2013","unstructured":"Elder ME, Nayak S, Collins SW, Lawson LA, Kelley JS, Herzog RW, et al. B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease. J Pediatr. 2013;163:847\u201354.e1.","journal-title":"J Pediatr"},{"key":"1771_CR19","doi-asserted-by":"crossref","unstructured":"Chan MY, Jalil JA, Yakob Y, Wahab SAA, Ali EZ, Khalid MKNM, et al. Genotype, phenotype and treatment outcomes of 17 Malaysian patients with infantile-onset Pompe disease and the identification of 3 novel GAA variants. Orphanet J Rare Dis. 2023;18:231.","DOI":"10.1186\/s13023-023-02848-6"},{"key":"1771_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01263-3","volume":"8","author":"V Roig-Zamboni","year":"2017","unstructured":"Roig-Zamboni V, Cobucci-Ponzano B, Iacono R, Ferrara MC, Germany S, Bourne Y, et al. Structure of human lysosomal acid \u03b1-glucosidase\u2013a guide for the treatment of Pompe disease. Nat Commun. 2017;8:1111.","journal-title":"Nat Commun"},{"key":"1771_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/ijns6020031","volume":"6","author":"T Sawada","year":"2020","unstructured":"Sawada T, Kido J, Nakamura K. Newborn Screening for Pompe Disease. Int J Neonatal Screen. 2020;6:31.","journal-title":"Int J Neonatal Screen"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01771-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01771-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01771-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:11:19Z","timestamp":1746169879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01771-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1771"],"URL":"https:\/\/doi.org\/10.1038\/s41431-024-01771-z","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"21 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was not required as all cases reviewed were from the published literature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}